Thought Leadership
ProPharma’s team of dedicated experts is at the forefront of both existing and emerging industry trends. ProPharma’s team inspires tomorrow by leveraging rich data insights across our service lines and functional areas to develop innovative solutions that answer the most complex needs of both existing and prospective clients.
European Pharma Regulations: 2024 Review and 2025 Trends to Watch
Gaining a Competitive Edge: 2024's European Pharma Regulatory Review & Trends to Look for in 2025 and Beyond As the pharmaceutical landscape in Europe evolves rapidly, regulatory frameworks are adapted to accommodate the increasing complexity of drug development, particularly for innovative...
A Journey Through ProPharma's REMS Program Support
This fictional story illustrates how ProPharma can seamlessly support a REMS program to ensure patient safety, access to medication, and regulatory compliance. Through scenarios involving healthcare providers like Dr. Emily and patients like Sarah, we demonstrate how ProPharma's services—from...
Patient Support Programs in India: Overcoming Barriers with Healthcare Access
Current Landscape of Medication and Healthcare Access in India India's healthcare system is a complex landscape with significant disparities in access to medical services and medications. Despite progress over the years, challenges such as high out-of-pocket costs, geographical disparities, and...
Resources
As the world’s largest RCO, ProPharma is committed to delivering dynamic research and perspectives crafted by world-class subject matter experts. ProPharma provides valuable insights to its clients to enable thoughtful decision making, as well as informed resource & investment allocation.
Drug Development Project Management Capability Self-Assessment
We believe an organization should successfully realize its early/ late-stage development goals through an effective project management ability. ProPharma's Drug Development Project Management Assessment is designed to help organizations evaluate their drug development project management...
General Project Management Capability Self-Assessment
ProPharma's General Project Management Capability Self-Assessment is designed to help organizations measure their alignment with strategic goals and their efficiency in managing projects. It evaluates alignment with organizational priorities, governance structures, execution efficiency, resource...
From Approval to Reimbursement: Navigating the Nordic Pharmaceutical Landscape
Discover how ProPharma supported a mid-sized European pharmaceutical company in achieving full reimbursement for their products across the Nordic markets of Denmark, Finland, and Sweden. This case study explores the strategic approach to overcoming diverse regulatory hurdles, navigating pricing...
Press Room
ProPharma is at the forefront of the life sciences industry and continues to innovate and elevate its position as the world’s largest RCO. Stay up to date on ProPharma’s latest news and most recent announcements.
ProPharma Appoints Brian Tuttle as Chief Financial Officer
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
Regulatory and Compliance excellence recognized for innovation across the product development lifecycle RALEIGH, NC, October 9, 2024: ProPharma, a leading global provider of regulatory, clinical, and compliance services for the life sciences industry, is pleased to announce it has won the...
ProPharma Names Dawn Sherman Chief Executive Officer
Veteran Life Sciences and Biopharmaceutical Industry Executive Previously Served as ProPharma CEO Raleigh, NC, September 26, 2024 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment...
Awards
With over 20 years of proven success, ProPharma continues to be acknowledged within the life sciences industry for providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. ProPharma proudly shares its recognition and achievements as its team works to improve the health and safety of patients.
ProPharma Appoints Brian Tuttle as Chief Financial Officer
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
Regulatory and Compliance excellence recognized for innovation across the product development lifecycle RALEIGH, NC, October 9, 2024: ProPharma, a leading global provider of regulatory, clinical, and compliance services for the life sciences industry, is pleased to announce it has won the...
ProPharma Names Dawn Sherman Chief Executive Officer
Veteran Life Sciences and Biopharmaceutical Industry Executive Previously Served as ProPharma CEO Raleigh, NC, September 26, 2024 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment...
Events
ProPharma is committed to engaging with both existing and prospective clients at the right time and in the right place. Speak with a member of the team at one of these upcoming events.
Inspiring the Future of Drug Development
We’ve developed a process that suits the today’s needs and a better experience for clients. Our industry is constantly changing. Let us help you accelerate your innovation.